Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-65-2
Name of the chemical
Lithium hydroxide
Concentration
N/A
EC/CAS
215-183-4
Name of the chemical
Lithium hydroxide
Concentration
N/A
General Information
Revision date
2015-12-06
Product name
Tribol GR 400-3 PD
supplier name
BP Oil Hellenic S.A
Icons in SDS
Company Information
company name
BP Oil Hellenic S.A
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSadvice@bp.com
GHS Information
Signal word
No
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
Product definition
Mixture
CLP CLASSIFICATION
Aquatic Chronic 3, H412
EU Classification
Directive 1999/45/EC [DPD] The product is classified as dangerous according to Directive 1999/45/EC and its amendments.
Classifications
R52/53
Environmental hazards
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. See Section 16 for the full text of the R phrases or H statements declared above. See sections 11 and 12 for more detailed information on health effects and symptoms and environmental hazards.
Signal word
No signal word.
Hazard statements
H412 - Harmful to aquatic life with long lasting effects.
Prevention
P273 - Avoid release to the environment.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1 elements 5-1:3) and Isodecyl diphenyl phosphite. May produce an allergic reaction.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
Defatting to the skin. Note: High Pressure Applications Injections through the skin resulting from contact with the product at high pressure constitute a major medical emergency.
